HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors

Clinical trial NCT07296341 · RECRUITING

Trial details

NCT number: NCT07296341
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Pancreatic Cancer With

Start date: 2026-01-08
Primary completion: 2027-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.